当前位置: X-MOL 学术Oncogene › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival.
Oncogene ( IF 6.9 ) Pub Date : 2019-Jan-01 , DOI: 10.1038/s41388-018-0426-6
S M Gilbert 1 , C J Oliphant 1 , S Hassan 2 , A L Peille 3 , P Bronsert 4, 5, 6 , S Falzoni 7 , F Di Virgilio 7 , S McNulty 1 , R Lara 1
Affiliation  

The ATP-gated receptor P2X7 is expressed in multiple malignant tumours including neuroblastoma, melanoma, prostate, lung and breast. P2X7 has a significant role in mediating diverse cell responses, which upon dysregulation are associated with tumour initiation and development. The rapid, ATP-mediated activation of P2X7 induces a fast-inward cation current in cells. However, prolonged ATP-mediated activation of P2X7 leads to formation of a pore that increases membrane permeability and eventually causes cell death. This presents a potential paradox, as the tumour microenvironment contains extracellular ATP at levels sufficient to activate the P2X7 pore and trigger cell death. However, P2X7 expression is associated with enhanced cancer cell survival, proliferation and metastatic potential. At least one distinct conformational form of P2X7, termed non-pore functional P2X7 (nfP2X7), has been described, which is not able to form a functional pore. We demonstrate for the first time in this study that exposure to a high ATP concentration, equivalent to those measured in the tumour microenvironment, drives nfP2X7 expression and also that nfP2X7 is essential for tumour cell survival. We show that monoclonal antibodies raised against a P2X7 amino acid sequence (200-216), whose conformation is distinct from that of wild-type (WT) P2X7, bind specifically to nfP2X7 expressed on the surface of tumour cells. We also show that nfP2X7 is broadly expressed in patient-derived tumour sections from a wide range of cancers. Therefore, antibodies raised against E200 provide tools that can differentiate between forms of the P2X7 receptor that have a key role in cancer.

中文翻译:

肿瘤微环境中的 ATP 驱动 nfP2X7 的表达,这是癌细胞存活的关键介质。

ATP 门控受体 P2X 7在多种恶性肿瘤中表达,包括神经母细胞瘤、黑色素瘤、前列腺、肺和乳腺。P2X 7在介导多种细胞反应方面具有重要作用,这些反应在失调时与肿瘤的发生和发展有关。ATP 介导的 P2X 7的快速激活会在细胞中诱导快速内向的阳离子电流。然而,延长 ATP 介导的 P2X 7激活会导致形成孔,从而增加膜通透性并最终导致细胞死亡。这提出了一个潜在的悖论,因为肿瘤微环境中包含的细胞外 ATP 水平足以激活 P2X 7孔并引发细胞死亡。然而,P2X 7表达与增强的癌细胞存活、增殖和转移潜能有关。已经描述了至少一种不同构象形式的 P2X 7,称为非孔功能性 P2X 7 (nfP2X 7 ),它不能形成功能性孔。我们在本研究中首次证明,暴露于高 ATP 浓度(相当于在肿瘤微环境中测量的浓度)会驱动 nfP2X 7表达,并且 nfP2X 7对肿瘤细胞存活至关重要。我们展示了针对 P2X 7氨基酸序列 (200-216)产生的单克隆抗体,其构象不同于野生型 (WT) P2X 7,特异性结合在肿瘤细胞表面表达的nfP2X 7。我们还表明,nfP2X 7在来自多种癌症的患者来源的肿瘤切片中广泛表达。因此,针对 E200 产生的抗体提供了可以区分在癌症中起关键作用的 P2X 7受体形式的工具。
更新日期:2018-08-07
down
wechat
bug